Video content above is prompted by the following:
- (SMITH) The approval of fezolinetant for moderate to severe VMS was based on the SKYLIGHT 1, SKYLIGHT 2, and SKYLIGHT 4 trials. Briefly describe the methodology of these studies.
- (FIFFICK) What were the key safety and efficacy results from the SKYLIGHT studies?
